{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:50:33Z","timestamp":1753890633472,"version":"3.41.2"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Dent. Med."],"abstract":"<jats:p>Periodontitis is a chronic inflammatory disease impacting the supporting structures of teeth, with significant global pervasiveness and systemic health implications. Current treatments, such as scaling and root planning (SRP) and adjunctive antibiotics, face challenges including antibiotic resistance, infection recurrence, and incomplete tissue regeneration. Bestatin, a dipeptide aminopeptidase inhibitor, has shown potential as a novel therapeutic agent due to its targeted antimicrobial effects against <jats:italic>Porphyromonas gingivalis (P. gingivalis),<\/jats:italic> biofilm modulation, and anti-inflammatory properties. <jats:italic>in vitro<\/jats:italic> studies revealed bestatin's selective bacteriostatic effects against P. gingivalis, inhibiting bacterial growth and biofilm development without affecting commensal bacteria. <jats:italic>in vivo<\/jats:italic> studies demonstrated that bestatin modulated inflammatory responses and prevented necrotic abscess formation in guinea pig models, suggesting its potential to suppress <jats:italic>P. gingivalis<\/jats:italic> growth through alternative pathways. However, no clinical trials were identified, highlighting a significant gap in the translation of preclinical findings into human periodontal therapy. The current review highlights Bestatin as a promising therapeutic representative for periodontitis, where it is involved in inhibiting modulating biofilms, reducing tissue destruction, and <jats:italic>P. gingivalis<\/jats:italic>, in preclinical studies. Compared to traditional therapies, bestatin provides unique advantages, non-cytotoxicity, including specificity, and dual action against microbial dysbiosis along with biofilm-associated resistance.<\/jats:p>","DOI":"10.3389\/fdmed.2025.1571989","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T04:10:35Z","timestamp":1747109435000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Role of bestatin as a treatment for periodontitis"],"prefix":"10.3389","volume":"6","author":[{"given":"Sudhir","family":"Rama Varma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bader Mohamed Moustafa","family":"Elagha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayaraj K.","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asok","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3390\/jcm8081135","article-title":"Periodontitis: a multifaceted disease of tooth-supporting tissues","volume":"8","author":"K\u00f6n\u00f6nen","year":"2019","journal-title":"J Clin Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.36437\/ijdrd.2023.5.4.D","article-title":"Alveolar bone destruction in periodontitis-an overview","volume":"5","author":"Dave","year":"2023","journal-title":"Int J Drug Res Dent Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1177\/23800844211041911","article-title":"Impact of periodontal disease on the quality of life of older people in Indonesia: a qualitative study","volume":"7","author":"Hijryana","year":"2022","journal-title":"JDR Clin Transl Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5142","DOI":"10.3390\/ijms23095142","article-title":"Impact of oral microbiome in periodontal health and periodontitis: a critical review on prevention and treatment","volume":"23","author":"Di Stefano","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/JPER.22-0241","article-title":"Epidemiological and sociodemographic transitions of severe periodontitis incidence, prevalence, and disability-adjusted life years for 21 world regions and globally from 1990 to 2019: an age-period-cohort analysis","volume":"94","author":"Cui","year":"2023","journal-title":"J Periodontol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/9720947","article-title":"Periodontal health and disease in the context of systemic diseases","volume":"2023","author":"Isola","year":"2023","journal-title":"Mediat Inflamm"},{"key":"B7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/prd.12294","article-title":"Periodontal disease and adverse pregnancy outcomes","volume":"83","author":"Bobetsis","year":"2020","journal-title":"Periodontol 2000"},{"key":"B8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/jcpe.13230","article-title":"Adjunctive effect of locally delivered antimicrobials in periodontitis therapy: a systematic review and meta-analysis","volume":"47","author":"Herrera","year":"2020","journal-title":"J Clin Periodontol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"7217","DOI":"10.3390\/ijms25137217","article-title":"Therapeutic strategies and genetic implications for periodontal disease management: a systematic review","volume":"25","author":"Laforgia","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"6916","DOI":"10.1073\/pnas.88.16.6916","article-title":"Leucine aminopeptidase: bestatin inhibition and a model for enzyme-catalyzed peptide hydrolysis","volume":"88","author":"Burley","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.3390\/ijms19092714","article-title":"Peptides as therapeutic agents for inflammatory-related diseases","volume":"19","author":"La Manna","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/JPER.22-0614","article-title":"Bestatin as a treatment modality in experimental periodontitis","volume":"94","author":"Kaminska","year":"2023","journal-title":"J Periodontol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0182164","DOI":"10.1371\/journal.pone.0182164","article-title":"Mechanisms by which porphyromonas gingivalis evades innate immunity","volume":"12","author":"Abdi","year":"2017","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2174\/1389200013338748","article-title":"Bestatin as an experimental tool in mammals","volume":"2","author":"Scornik","year":"2001","journal-title":"Curr Drug Metab"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e202400052","DOI":"10.1002\/asia.202400052","article-title":"Recent advances of aminopeptidases-responsive small-molecular probes for bioimaging","volume":"19","author":"Xu","year":"2024","journal-title":"Chem Asian J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1902\/jop.2001.72.6.714","article-title":"Effects of dipeptide bestatin on porphyromonas gingivalis and epithelial cells","volume":"72","author":"Labb\u00e9","year":"2001","journal-title":"J Periodontol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.cyto.2008.10.011","article-title":"Bestatin, an inhibitor for aminopeptidases, modulates the production of cytokines and chemokines by activated monocytes and macrophages","volume":"44","author":"Lkhagvaa","year":"2008","journal-title":"Cytokine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3109\/08910609209141307","article-title":"Effect of protease inhibitors on in vitro growth of porphyromonas gingivalis","volume":"5","author":"Grenier","year":"1992","journal-title":"Microb Ecol Health Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1574-6968.1994.tb07221.x","article-title":"Selective growth inhibition of porphyromonas gingivalis by bestatin","volume":"123","author":"Grenier","year":"1994","journal-title":"FEMS Microbiol Lett"},{"key":"B20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1034\/j.1399-302x.2001.160403.x","article-title":"Studies on the aminopeptidase activities of porphyromonas gingivalis","volume":"16","author":"Grenier","year":"2001","journal-title":"Oral Microbiol Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1515\/hsz-2012-0222","article-title":"Gingipain aminopeptidase activities in porphyromonas gingivalis","volume":"393","author":"Veillard","year":"2012","journal-title":"Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11515-016-1418-y","article-title":"Antibacterial effect of bestatin during periodontitis","volume":"11","author":"Jain","year":"2016","journal-title":"Front Biol (Beijing)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.drudis.2007.10.018","article-title":"Drug delivery from the oral cavity: focus on a novel mechatronic delivery device","volume":"13","author":"Scholz","year":"2008","journal-title":"Drug Discov Today"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/pathogens10101310","article-title":"Bacterial antibiotic resistance: the most critical pathogens","volume":"10","author":"Mancuso","year":"2021","journal-title":"Pathogens"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.2174\/092986732266615053021052","article-title":"Insights on antimicrobial resistance, biofilms and the use of phytochemicals as new antimicrobial agents","volume":"22","author":"Borges","year":"2015","journal-title":"Curr Med Chem"},{"key":"B26","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1080\/23744235.2024.2379492","article-title":"Phage therapy: an alternative treatment modality for MDR bacterial infections","volume":"56","author":"Pal","year":"2024","journal-title":"Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/idj.12221","article-title":"Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases","volume":"66","author":"Golub","year":"2016","journal-title":"Int Dent J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2174\/1568009043333041","article-title":"Leukotriene A4 hydrolase as a target for cancer prevention and therapy","volume":"4","author":"Chen","year":"2004","journal-title":"Curr Cancer Drug Targets"},{"key":"B29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12967-018-1516-5","article-title":"Establishment of lung cancer patient-derived xenograft models and primary cell lines for lung cancer study","volume":"16","author":"Jiang","year":"2018","journal-title":"J Transl Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ebiom.2017.09.029","article-title":"A small molecule inhibitor of the beta-catenin-TCF4 interaction suppresses colorectal cancer growth in vitro and in vivo","volume":"25","author":"Shin","year":"2017","journal-title":"EBioMedicine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/B978-0-323-61211-1.00009-7","article-title":"Systemic antibacterial agents","author":"Snodgrass","year":"2021","journal-title":"Compr Dermatol Drug Ther"},{"key":"B32","doi-asserted-by":"publisher","first-page":"398","DOI":"10.2174\/156720110793566290","article-title":"Local delivery of minocycline hydrochloride: a therapeutic paradigm in periodontal diseases","volume":"7","author":"Javed","year":"2010","journal-title":"Curr Drug Delivery"},{"key":"B33","doi-asserted-by":"publisher","first-page":"879131","DOI":"10.3389\/fdmed.2022.879131","article-title":"Modulating the immune response in periodontitis","volume":"3","author":"Bezerra","year":"2022","journal-title":"Front Dent Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/j.1600-051X.2008.01254.x","article-title":"Azithromycin as an adjunctive treatment of aggressive periodontitis: 12-months randomized clinical trial","volume":"35","author":"Haas","year":"2008","journal-title":"J Clin Periodontol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1600-051X.2010.01632.x","article-title":"Amoxicillin and metronidazole as an adjunctive treatment in generalized aggressive periodontitis at initial therapy or re-treatment: a randomized controlled clinical trial","volume":"38","author":"Griffiths","year":"2011","journal-title":"J Clin Periodontol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1007\/s00784-021-03869-w","article-title":"The effect of drug dose and duration of adjuvant amoxicillin-plus-metronidazole to full-mouth scaling and root planing in periodontitis: a systematic review and meta-analysis","volume":"25","author":"Zhao","year":"2021","journal-title":"Clin Oral Investig"},{"key":"B37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.identj.2022.01.005","article-title":"Chlorhexidine in dentistry: pharmacology, uses, and adverse effects","volume":"72","author":"Deus","year":"2022","journal-title":"Int Dent J"},{"key":"B38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/1040841X.2023.2197481","article-title":"Antibiotic resistance in the microbiota of periodontitis patients: an update of current findings","volume":"50","author":"Ng","year":"2024","journal-title":"Crit Rev Microbiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/s12903-022-02530-6","article-title":"Advances in novel therapeutic approaches for periodontal diseases","volume":"22","author":"Haque","year":"2022","journal-title":"BMC Oral Health"},{"key":"B40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/omi.12385","article-title":"Multispecies biofilm behavior and host interaction support the association of tannerella serpentiformis with periodontal health","volume":"38","author":"Kendlbacher","year":"2023","journal-title":"Mol Oral Microbiol"}],"container-title":["Frontiers in Dental Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdmed.2025.1571989\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T04:10:37Z","timestamp":1747109437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdmed.2025.1571989\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":40,"alternative-id":["10.3389\/fdmed.2025.1571989"],"URL":"https:\/\/doi.org\/10.3389\/fdmed.2025.1571989","relation":{},"ISSN":["2673-4915"],"issn-type":[{"type":"electronic","value":"2673-4915"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"article-number":"1571989"}}